A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years

Vaccine

Volumn 29, Issue 31, 2011, Pages 4947-4952

  Tennis, Patricia ^a   Toback, Seth L ^b   Andrews, Elizabeth ^a   McQuay, Lisa J ^a   Ambrose, Christopher S ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b MEDIMMUNE   (United States)

Author keywords

Asthma; Live attenuated influenza vaccine; Trivalent inactivated influenza vaccine

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; ASTHMA; CHILD; CONJUNCTIVAL HEMORRHAGE; CROUP; DATA BASE; DRUG FEVER; DRUG SAFETY; DRUG USE; EMERGENCY WARD; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; IMMUNOCOMPETENCE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; OTITIS MEDIA; POPULATION; POSTMARKETING SURVEILLANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SEIZURE; VIRUS INFECTION; WHEEZING;

CHILD, PRESCHOOL; COHORT STUDIES; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; UNITED STATES; VACCINATION; VACCINES, ATTENUATED;

EID: 80053043043     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.113     Document Type: Article

References (22)

1. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59:1-62.
2. Belshe R.B., Ambrose C., Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Vaccine 2008, 26S:D10-D16.
3. Advisory Committee on Immunization Practices. ACIP Meeting Minutes, October 24-25, 2007. Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: Accessed August 16, 2010. http://www.cdc.gov/vaccines/recs/acip/downloads/min-oct07.pdf.
4. Rothman K. Epidemiology, an introduction 2002, Oxford University Press, New York.
5. Bundy D.G. Hospitalizations with primary versus secondary discharge diagnoses of asthma: implications for pediatric asthma surveillance. J Pediatr 2007, 150:446-449. 9 e1.
6. Izurieta H.S., Haber P., Wise R.P., Iskander J., Pratt D., Mink C., et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 2005, 294:2720-2725.
7. Haber P, Aarana J, Walton K. Safety of live attenuated influenza vaccine in children aged 24-59 months, vaccine adverse event reporting system (VAERS), 2007-2009. In: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2009 September 12-15, San Francisco, CA.
8. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007;120:S94-138.
9. Barrueto L., Mallol J., Figueroa L. Beclomethasone dipropionate and salbutamol by metered dose inhaler in infants and small children with recurrent wheezing. Pediatr Pulmonol 2002, 34:52-57.
10. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356:685-696.
11. Esposito S., Marchisio P., Bosis S., Lambertini L., Claut L., Faelli N., et al. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine 2006, 24:629-635.
12. Lehtinen P., Ruohola A., Vanto T., Vuorinen T., Ruuskanen O., Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 2007, 119:570-575.
13. Lombardi E., Morgan W.J., Wright A.L., Stein R.T., Holberg C.J., Martinez F.D. Cold air challenge at age 6 and subsequent incidence of asthma. A longitudinal study. Am J Respir Crit Care Med 1997, 156:1863-1869.
14. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005, 171:137-141.
15. Teper A.M., Kofman C.D., Szulman G.A., Vidaurreta S.M., Maffey A.F. Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma. Am J Respir Crit Care Med 2005, 171:587-590.
16. FluMist®. In: Influenza virus vaccine live, Intranasal, Full prescribing information. Gaithersburg, MD: MedImmune; 2010.
17. Fleming D.M., Crovari P., Wahn U., Klemola T., Schlesinger Y., Langussis A., et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006, 25:860-869.
18. Gorse G.J., O'Connor T.Z., Young S.L., Habib M.P., Wittes J., Neuzil K.M., et al. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. Chest 2006, 130:1109-1116.
19. King J.C., Fast P.E., Zangwill K.M., Weinberg G.A., Wolff M., Yan L., et al. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. Pediatr Infect Dis J 2001, 20:1124-1131.
20. King J.C., Treanor J., Fast P.E., Wolff M., Yan L., Iacuzio D., et al. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis 2000, 181:725-728.
21. Levin M.J., Song L.Y., Fenton T., Nachman S., Patterson J., Walker R., et al. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine 2008, 26:4210-4217.
22. Halasa N, Englund J, Nachman S, Weinberg G, Huber VC, Allison K, et al. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. In: Pediatric Academic Societies Annual Meeting, 2009, May 2-5, Baltimore, MD.